Citigroup Initiates Coverage On Alpha Tau Medical with Buy Rating, Announces Price Target of $21
Citigroup analyst Neena Bitritto-Garg initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price Target of $21.